References
- Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance. Nat Rev Cancer 2005;5:275–84.
- Li HY, Say EH, Zhou XF. Isolation and characterization of neural crest progenitors from adult dorsal root ganglia. Stem Cells 2007;25:2053–65.
- Ishimura D, Yamamoto N, Tajima K, Ohno A, Yamamoto Y, Washimi O, Differentiation of adipose-derived stromal vascular fraction culture cells into chondrocytes using the method of cell sorting with a mesenchymal stem cell marker. Tohoku J Exp Med 2008;216:149–56.
- Nakamura T, Endo K, Kinoshita S. Identification of human oral keratinocyte stem/progenitor cells by neurotrophin receptor p75 and the role of neurotrophin/p75 signaling. Stem Cells 2007;25:628–38.
- Okumura T, Shimada Y, Imamura M, Yasumoto S. Neurotrophin receptor p75NTR characterizes human esophageal keratinocyte stem cells in vitro. Oncogene 2003;22:4017–26.
- Huang SD, Yuan Y, Liu XH, Gong DJ, Bai CG, Wang F, Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas. BMC Cancer 2009;9:9.
- Okumura T, Tsunoda S, Mori Y, Ito T, Kikuchi K, Wang TC, The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma. Clin Cancer Res 2006;12:5096–103.
- Søland TM, Brusevold IJ, Koppang HS, Schenck K, Bryne M. Nerve growth factor receptor (p75NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma. Histopathology 2008;53:62–72.
- Barnes L, Eveson JW, Reichart P, Sidransky D 2005. Pathology and genetics of head and neck tumours (WHO classification of tumours). Lyon: IARC Press. p 385–90.
- Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004;427:843–8.
- Wehrman T, He X, Raab B, Dukipatti A, Blau H, Garcia KC. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 2007;53:25–38.
- Yan C, Liang Y, Nylander KD, Wong J, Rudavsky RM, Saragovi HU, p75-nerve growth factor as an antiapoptotic complex: independence versus cooperativity in protection from enediyne chemotherapeutic agents. Mol Pharmacol 2002;61:710–19.
- Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001;98:3156–61.
- Quade BJ, Yang A, Wang Y, Sun D, Park J, Sheets EE, Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 2001;80:24–9.
- Watt FM. Terminal differentiation of epidermal keratinocytes. Curr Opin Cell Biol 1989;1:1107–15.
- Marchetti D, Aucoin R, Blust J, Murry B, Greiter-Wilke A. p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells. J Cell Biochem 2004;91:206–15.
- Gangemi R, Paleari L, Orengo AM, Cesario A, Chessa L, Ferrini S, Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem 2009;16:1688–703.
- Zhou L, Wei X, Cheng L, Tian J, Jiang JJ. CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope 2007;117:455–60.
- Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007;104:973–8.